Glenn Batchelder ’84 is president and CEO of Civitas Therapeutics. Among the firm’s respiratory therapies is ARCUS®, which delivers precise dosages with a breath-activated device.
Batchelder has more than 25 years of experience in senior business and technical leadership roles, including as CEO of two successful biotech companies prior to Civitas. Prior to co-founding Civitas, he was CEO and the first employee of BIND Biosciences, a leading nanotherapeutic company.
Before BIND, Batchelder was CEO of Acceleron Pharma, building the company from a research start-up to a clinical stage company with a promising bone loss therapy in the clinic and a robust preclinical pipeline. Prior to Acceleron, Batchelder was Senior Vice President of Operations at Millennium Pharmaceuticals where he played an integral leadership role in the launch of VELCADE® and was responsible for the commercial supply chain and technical operations for INTEGRILIN®.Batchelder received a B.S. in chemical engineering from Lehigh in 1984 and serves on the Board of Directors of the Massachusetts Biotechnology Council.